Macroaxis Story

Macroaxis News
  
By Vlad Skutelnik

October 9, 2019

In this article I will break down 5 Obamacare isntruments to have in your portfolio in November 2019. I will cover Select Medical Holdings Corpora, Globus Medical, NuVasive, Universal Health Services, and Tenet Healthcare Corporation
The Top 5 Obamacare stocks to own in November 2019

This list of potential positions covers Companies that count on Obamacare to take off. Health care services and providers including hospitals, clinics and nursing homes that hope to benefit from Obamacare program in USA. Please note, we provide buy hold or sell recommendation only in the context of selected investment horizon assuming investor has average attitude towards taking risk. Please also consider using Portfolio Positions Ratings and Equity Ratings tools to further calibrate your research.


Select Medical Holdings Corpora (SEM)

The company has Net Profit Margin of 2.74 % which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is considered to be average in the sector. In the same way, it shows Net Operating Margin of 12.17 % which entails that for every 100 dollars of revenue it generated 0.12 of operating income. The firm currently falls under 'Mid-Cap' category with total capitalization of 2.22 B. Select Medical Holdings has current Real Value of $19.69 per share. The regular price of the company is $16.71. At this time the company appears to be undervalued. This module measures value of Select Medical Holdings from inspecting the company fundamentals such as Operating Margin of 12.17 , Shares Outstanding of 135.62 M and Return On Equity of 10.71  as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend to buy undervalued stocks and to dispose of overvalued stocks since at some point securities prices and their ongoing real values will draw towards each other.

Globus Medical (GMED)

The company reported previous year revenue of 742.66 M. Net Income was 143.33 M with profit before overhead, payroll, taxes, and interest of 553.56 M. The firm currently falls under 'Mid-Cap' category with current market capitalization of 5.14 B.
Total Debt
Globus Medical retains regular Real Value of $56.09 per share. The prevalent price of the corporation is $50.49. At this time the corporation appears to be undervalued. This module calculates value of Globus Medical from evaluating the corporation fundamentals such as Current Valuation of 4.9 B, Return On Equity of 0.0018  and Return On Asset of 0.0016  as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we encourage to acquire undervalued assets and to sell overvalued assets since at some point stocks prices and their ongoing real values will come together.

NuVasive (NUVA)

The company reported previous year revenue of 1.13 B. Net Income was 52.43 M with profit before overhead, payroll, taxes, and interest of 790.55 M. The firm currently falls under 'Mid-Cap' category with current market capitalization of 3.39 B. NuVasive secures last-minute Real Value of $70.7 per share. The latest price of the firm is $63.7. At this time the firm appears to be undervalued. This module forecasts value of NuVasive from analyzing the firm fundamentals such as Profit Margin of (0.0005) , Return On Equity of (0.0001)  and Return On Asset of (0.38)  as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend to purchase undervalued stocks and to get rid of overvalued stocks since at some point entities prices and their ongoing real values will merge together. NuVasive competes with Edwards Lifesciences, EDAP TMS, Second Sight, Dynatronics, Electromed, ENCISION INC, Digirad, and Establishment Labs. NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for spine surgery. NuVasive, Inc. was founded in 1997 and is headquartered in San Diego, California. NuVasive operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 2600 people.

Universal Health Services (UHS)

The company has Net Profit Margin of 7.25 % which may imply that it executes well on its competitive polices and has a good control over its expenditures and variable costs. This is very large. In the same way, it shows Net Operating Margin of 15.62 % which entails that for every 100 dollars of revenue it generated 0.16 of operating income. This firm currently falls under 'Large-Cap' category with total capitalization of 12.85 B.
Total Debt
Universal Health competes with Eros International, Tenet Healthcare, Wellcare Health, UnitedHealth Group, Select Medical. Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, outpatient facilities, and behavioral health care facilities. Universal Health Services, Inc. founded in 1978 and is headquartered in King Of Prussia, Pennsylvania. Universal Health operates under Medical Care classification in USA and is traded on BATS Exchange. It employs 87000 people.

Tenet Healthcare Corporation (THC)

About 104.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.43. The entity recorded loss per share of 0.16. The entity last dividend was issued on 2000-03-13. The firm had 1:4 split on 2012-10-11. This firm currently falls under 'Mid-Cap' category with total capitalization of 2.34 B. Tenet Healthcare has current Real Value of $27.08 per share. The regular price of the company is $22.98. At this time the company appears to be undervalued. This module measures value of Tenet Healthcare from inspecting the company fundamentals such as Shares Outstanding of 103.45 M, Operating Margin of 15.08  and Return On Equity of 15.97  as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend to buy undervalued stocks and to dispose of overvalued stocks since at some point securities prices and their ongoing real values will draw towards each other.

Current 5 Obamacare Recommendations

Competition Technical Indicators

Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
 5.88  0.57  0.06  0.23  7.71  0.06 (6.77)  12.16 (10.05)  68.12 
 0.34 (0.04)  0.00  0.75  0.00 (0.0064)  0.00  0.56 (0.56)  1.69 
 0.10  0.00  0.22 (0.38)  0.05  0.28 (0.11)  0.23 (0.22)  0.59 
 0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00  0.00 
 3.11  0.51  0.15  0.25  2.95  0.11 (3.65)  8.04 (4.71)  22.31 
 0.84 (0.06)  0.00 (0.12)  0.00 (0.0442)  0.00  1.69 (2.23)  4.76 
 1.20 (0.06)  0.00 (0.11)  0.00 (0.0331)  0.00  2.06 (2.42)  8.83 
 0.19  0.04  0.16  0.54  0.27  0.22 (0.20)  0.36 (0.35)  2.07 
 1.13  0.17  0.14  0.20  1.10  0.1 (1.28)  2.46 (2.13)  13.47 
 1.24  0.15  0.11  0.15  1.34  0.10 (1.34)  2.58 (1.99)  7.30 

About Contributor

Vlad Skutelnik
   Vlad Skutelnik is a Macroaxis Contributor. Vlad covers stocks, funds, cryptocurrencies, and ETFs that are traded in North America focusing primarily on fundamentals, valuation and market volatility. He has many years of experience in fintech, predictive investment analytics, and risk management. View Profile
This story should be regarded as informational only and should not be considered as solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Macroaxis. Please refer to our Terms of Use for any information regarding our disclosure principles.

Did you try this?

Run Cryptocurrency Correlation Now

   

Cryptocurrency Correlation

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins and exchanges
All  Next Launch Module
See also Stocks Correlation. Please also try Price Transformation module to use price transformation models to analyze depth of different equity instruments across global markets.
Search macroaxis.com